Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgAMiri Stolovich-Rain, Alexander Rouvinski, Sujata Kumari et al.|Frontiers in Immunology|2023Cited by 22
Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015Kamilla Grønborg Laut, Leah Shepherd, Roxana Rădoi et al.|Eurosurveillance|2018Cited by 16
Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort studyYaakov Dickstein, Marco Falcone, Dafna Yahav et al.|Infection|2025Cited by 4
Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living With Human Immunodeficiency Virus: Evaluation of Clinical and Microbiome ParametersO Ziv, Hila Elinav, Avivit Cahn et al.|The Journal of Infectious Diseases|2024Cited by 2
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgAMiri Stolovich-Rain, Alexander Rouvinski, Sujata Kumari et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1